Roberta Ambrosini

5PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Condensed matter characterisation technique developmentMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 05, 2026
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy.

Francesco Dondi, Davide Lorenzo Bettini, Deborah Cosentini

|Sep 28, 2023
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.

Antonella Turla, Marta Laganà, Andrea Abate

|Jun 24, 2022
Different Lung Parenchyma Quantification Using Dissimilar Segmentation Software: A Multi-Center Study for COVID-19 Patients.

Camilla Risoli, Marco Nicolò, Davide Colombi

|Jun 03, 2020
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria.

Roberta Ambrosini, Maria Carolina Balli, Marta Laganà

|May 17, 2020
Dynamic contrast-enhanced MRI in oncology: how we do it.

Giuseppe Petralia, Paul E Summers, Andrea Agostini

Pageof 1

Frequent Collaborators

3 joint publications

Sandra Sigala

3 joint publications

Guido Alberto Massimo Tiberio

3 joint publications

Alfredo Berruti

2 joint publications

Salvatore Grisanti